Pfizer: presents new data at ASCO 2024

(CercleFinance.com) - Pfizer is presenting its progress in developing new approaches to oncology care and its cancer drugs at the American Society of Clinical Oncology (ASCO®) 2024 Annual Meeting, to be held in Chicago from 31 May to 4 June.


More than 50 abstracts, including 11 oral presentations, will be presented from Pfizer's portfolio of approved and pipeline therapies in the company's major tumor areas and scientific modalities, including small molecules, antibody-drug conjugates (ADCs) and bispecific antibodies.

We are delighted to participate in our first annual ASCO meeting following the creation of Pfizer's new oncology organization, where we will highlight our efforts to accelerate the development of breakthrough medicines that help people with cancer live better, longer lives, Pfizer said, adding that it looks forward to key data presentations from our newly developed portfolio, including additional evidence reinforcing the benefit of several approved drugs and promising new data from our large and diverse pipeline.


Copyright (c) 2024 CercleFinance.com. All rights reserved.